Saturday, February 2, 2019

Commonly used anti-rejection drug could be repurposed to treat some liver cancers

Research in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed to treat certain liver cancers.

from Top Health News -- ScienceDaily http://bit.ly/2MK3wwq
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

One tiny mutation may explain how bat viruses become human threats

Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with...